1,1-dichloroethene increases expression ISO RGD:732472 6480464 vinylidene chloride results in increased expression of HCK mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:732472 6480464 1, 2-Dimethylhydrazine results in increased expression of HCK mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of HCK mRNA CTD PMID:25380136 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCK mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:732471 6480464 Estradiol results in increased expression of HCK mRNA CTD PMID:31614463 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCK mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HCK mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HCK mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732472 6480464 Tetrachlorodibenzodioxin affects the expression of HCK mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732472 6480464 Tetrachlorodibenzodioxin results in increased expression of HCK mRNA CTD PMID:21041162 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HCK mRNA CTD PMID:21215274 2,6-di-tert-butyl-4-methylphenol affects expression EXP 6480464 Butylated Hydroxytoluene affects the expression of HCK mRNA CTD PMID:18539377 3-methylcholanthrene multiple interactions ISO RGD:732472 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HCK mRNA CTD PMID:23519560 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of HCK mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HCK mRNA CTD PMID:36041667 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of HCK mRNA CTD PMID:21346803 4-hydroxynon-2-enal decreases expression ISO RGD:732472 6480464 4-hydroxy-2-nonenal results in decreased expression of HCK mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:732472 6480464 Fenretinide results in increased expression of HCK mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects methylation ISO RGD:732471 6480464 Decitabine affects the methylation of HCK promoter CTD PMID:17344919 5-aza-2'-deoxycytidine increases expression ISO RGD:732471 6480464 Decitabine results in increased expression of HCK protein CTD PMID:17344919 5-aza-2'-deoxycytidine multiple interactions ISO RGD:732471 6480464 [Decitabine affects the methylation of HCK promoter] which affects the expression of HCK mRNA CTD PMID:17344919 acetamide increases expression EXP 6480464 acetamide results in increased expression of HCK mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO RGD:732471 6480464 Aspirin results in decreased expression of HCK mRNA CTD PMID:15928584 Aflatoxin B2 alpha increases methylation ISO RGD:732471 6480464 aflatoxin B2 results in increased methylation of HCK intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:732472 6480464 Tretinoin results in decreased expression of HCK mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:732471 6480464 Tretinoin results in increased expression of HCK mRNA CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HCK mRNA CTD PMID:16483693 amosite asbestos increases activity ISO RGD:732472 6480464 Asbestos, Amosite results in increased activity of HCK protein CTD PMID:29112861 antirheumatic drug decreases expression ISO RGD:732471 6480464 Antirheumatic Agents results in decreased expression of HCK mRNA CTD PMID:24449571 arsenite(3-) increases methylation ISO RGD:732471 6480464 arsenite results in increased methylation of HCK promoter CTD PMID:23974009 ATP multiple interactions ISO RGD:732471 6480464 [Curcumin binds to 4-bis(2-chloroethyl)aminobenzaldehyde] inhibits the reaction [HCK protein binds to Adenosine Triphosphate] CTD PMID:33617879 ATP affects binding ISO RGD:732471 6480464 HCK protein binds to Adenosine Triphosphate CTD PMID:33617879 bathocuproine disulfonic acid multiple interactions ISO RGD:732471 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA] CTD PMID:15477007 benzalkonium chloride multiple interactions ISO RGD:732472 6480464 [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HCK mRNA CTD PMID:30171875 benzo[a]pyrene increases mutagenesis ISO RGD:732471 6480464 Benzo(a)pyrene results in increased mutagenesis of HCK gene CTD PMID:25435355 benzo[a]pyrene increases methylation ISO RGD:732471 6480464 Benzo(a)pyrene results in increased methylation of HCK exon CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HCK mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HCK mRNA CTD PMID:36041667 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HCK mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A decreases expression ISO RGD:732472 6480464 bisphenol A results in decreased expression of HCK mRNA CTD PMID:25594700 , PMID:35598803 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HCK mRNA CTD PMID:36041667 cadmium atom decreases expression ISO RGD:732471 6480464 Cadmium results in decreased expression of HCK mRNA CTD PMID:24376830 cadmium dichloride multiple interactions ISO RGD:732471 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA CTD PMID:12634122 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of HCK mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:732471 6480464 Calcitriol results in decreased expression of HCK mRNA CTD PMID:26485663 carbon nanotube increases activity ISO RGD:732472 6480464 Nanotubes, Carbon results in increased activity of HCK protein CTD PMID:29112861 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of HCK mRNA CTD PMID:18500788 chloroprene decreases expression ISO RGD:732472 6480464 Chloroprene results in decreased expression of HCK mRNA CTD PMID:23125180 chromium(6+) affects expression ISO RGD:732472 6480464 chromium hexavalent ion affects the expression of HCK mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:732471 6480464 Cisplatin results in increased expression of HCK mRNA CTD PMID:27594783 clothianidin increases expression ISO RGD:732471 6480464 clothianidin results in increased expression of HCK mRNA CTD PMID:31626844 cobalt dichloride increases expression ISO RGD:732471 6480464 cobaltous chloride results in increased expression of HCK mRNA CTD PMID:23052192 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of HCK mRNA CTD PMID:27523638 curcumin multiple interactions ISO RGD:732471 6480464 [Curcumin binds to 3 more ... CTD PMID:33617879 curcumin decreases activity ISO RGD:732471 6480464 Curcumin analog results in decreased activity of HCK protein CTD PMID:33617879 deoxynivalenol increases phosphorylation ISO RGD:732471 6480464 deoxynivalenol results in increased phosphorylation of HCK protein CTD PMID:20181660 deoxynivalenol affects response to substance ISO RGD:732472 6480464 HCK protein affects the susceptibility to deoxynivalenol CTD PMID:22491426 deoxynivalenol multiple interactions ISO RGD:732472 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... CTD PMID:15772366 dexamethasone increases expression ISO RGD:732472 6480464 Dexamethasone results in increased expression of HCK mRNA CTD PMID:21041162 dibutyl phthalate decreases expression ISO RGD:732472 6480464 Dibutyl Phthalate results in decreased expression of HCK mRNA CTD PMID:17361019 , PMID:21266533 dichromium trioxide multiple interactions ISO RGD:732471 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA CTD PMID:12634122 diclofenac increases expression ISO RGD:732472 6480464 Diclofenac results in increased expression of HCK mRNA CTD PMID:26934552 diethyl malate affects expression ISO RGD:732472 6480464 diethyl malate affects the expression of HCK mRNA CTD PMID:24814887 diethylstilbestrol increases expression ISO RGD:732472 6480464 Diethylstilbestrol results in increased expression of HCK mRNA CTD PMID:21041162 dorsomorphin multiple interactions ISO RGD:732471 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of HCK mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:732471 6480464 entinostat results in increased expression of HCK mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:732471 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HCK mRNA CTD PMID:27188386 folic acid decreases expression ISO RGD:732472 6480464 Folic Acid results in decreased expression of HCK mRNA CTD PMID:25629700 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HCK mRNA CTD PMID:22061828 ionomycin multiple interactions ISO RGD:732471 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA CTD PMID:15477007 lead diacetate multiple interactions ISO RGD:732471 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA CTD PMID:12634122 lipopolysaccharide increases expression ISO RGD:732472 6480464 Lipopolysaccharides results in increased expression of HCK mRNA CTD PMID:27339419 lipopolysaccharide increases expression ISO RGD:732471 6480464 Lipopolysaccharides results in increased expression of HCK mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:732471 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HCK mRNA CTD PMID:35811015 mercury dichloride increases activity ISO RGD:732472 6480464 Mercuric Chloride results in increased activity of HCK protein CTD PMID:10092522 mercury dichloride increases activity ISO RGD:732471 6480464 Mercuric Chloride results in increased activity of HCK protein CTD PMID:14551197 mercury dichloride multiple interactions ISO RGD:732472 6480464 Mercuric Chloride promotes the reaction [HCK protein results in increased phosphorylation of CBL protein] CTD PMID:10092522 methotrexate affects expression ISO RGD:732472 6480464 Methotrexate affects the expression of HCK mRNA CTD PMID:18502557 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases phosphorylation ISO RGD:732471 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of HCK protein CTD PMID:25980585 N-methyl-4-phenylpyridinium increases expression ISO RGD:732471 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HCK mRNA CTD PMID:24810058 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of HCK mRNA CTD PMID:25380136 nickel atom decreases expression ISO RGD:732471 6480464 Nickel results in decreased expression of HCK mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:732471 6480464 Nickel results in increased expression of HCK mRNA CTD PMID:25583101 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of HCK mRNA CTD PMID:23439660 ozone decreases expression EXP 6480464 Ozone results in decreased expression of HCK mRNA CTD PMID:16330353 ozone multiple interactions ISO RGD:732472 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HCK mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:732471 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HCK mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:732472 6480464 Acetaminophen affects the expression of HCK mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HCK mRNA CTD PMID:33387578 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:732471 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA CTD PMID:15477007 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:732472 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HCK mRNA CTD PMID:23519560 pirinixic acid decreases expression ISO RGD:732472 6480464 pirinixic acid results in decreased expression of HCK mRNA CTD PMID:17426115 ponatinib decreases activity ISO RGD:732471 6480464 ponatinib results in decreased activity of HCK protein CTD PMID:19878872 pyrrolidine dithiocarbamate multiple interactions ISO RGD:732471 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA] CTD PMID:15477007 resveratrol decreases expression ISO RGD:732471 6480464 resveratrol results in decreased expression of HCK mRNA CTD PMID:15280659 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of HCK mRNA CTD PMID:25905778 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of HCK mRNA CTD PMID:25905778 rotenone increases expression ISO RGD:732471 6480464 Rotenone results in increased expression of HCK mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:732471 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HCK mRNA CTD PMID:35811015 S-nitroso-N-acetyl-D-penicillamine decreases expression EXP 6480464 S-Nitroso-N-Acetylpenicillamine results in decreased expression of HCK mRNA CTD PMID:12102619 SB 431542 increases expression ISO RGD:732471 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of HCK protein CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:732471 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:732472 6480464 Silver results in decreased expression of HCK mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:732472 6480464 Silver results in decreased expression of HCK mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:732471 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA, sodium arsenite promotes the reaction [HCK protein binds to CAPRIN1 protein] CTD PMID:12634122 , PMID:33939924 Soman increases expression EXP 6480464 Soman results in increased expression of HCK mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of HCK mRNA CTD PMID:25905778 sulforaphane increases expression ISO RGD:732471 6480464 sulforaphane results in increased expression of HCK mRNA CTD PMID:26833863 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of HCK mRNA CTD PMID:26141394 tamibarotene increases expression ISO RGD:732471 6480464 tamibarotene results in increased expression of HCK mRNA CTD PMID:15498508 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HCK mRNA CTD PMID:32741896 testosterone enanthate affects expression ISO RGD:732471 6480464 testosterone enanthate affects the expression of HCK mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:732472 6480464 Carbon Tetrachloride results in increased expression of HCK mRNA CTD PMID:27339419 , PMID:31919559 tetraphene increases expression ISO RGD:732472 6480464 benz(a)anthracene results in increased expression of HCK mRNA CTD PMID:26377693 thioacetamide increases methylation EXP 6480464 Thioacetamide results in increased methylation of HCK promoter CTD PMID:27914986 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HCK mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:732472 6480464 titanium dioxide results in decreased expression of HCK mRNA CTD PMID:29264374 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HCK mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:732471 6480464 trichostatin A results in increased expression of HCK mRNA CTD PMID:24935251 triphenylstannane increases expression ISO RGD:732471 6480464 triphenyltin results in increased expression of HCK protein CTD PMID:12788061 valproic acid affects expression ISO RGD:732471 6480464 Valproic Acid affects the expression of HCK mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:732471 6480464 Valproic Acid results in increased expression of HCK mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:732471 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HCK mRNA CTD PMID:27188386
